Versions Compared


  • This line was added.
  • This line was removed.
  • Formatting was changed.


Inclusion of vetted, tested and validated controlled terminologies into imaging arms of clinical trials is essential in adding value of imaging as a biomarker in cross-cutting correlative studies. Controlled terminologies such as the one described herein for assessment of gliomas can be effectively used by domain experts following a relatively short training period. Technologies developed through the caBIG initiative provide an effective and efficient framework for federated imaging assessments that can expedite cross-correlative analysis with other data repositories (e.g. genomics / proteomics / pathology).

Updates to the The Cancer Genome Atlas Glioblastoma Multiforme Collection (TCGA-GBM) imaging data set are being stored within TCIA and the research group is continuing to expand on their work.